October 04, 2004
Johnson & Johnson has received a subpoena requesting documents about the sales and marketing of Procrit, a prescription treatment for anemia. Sales representatives of drug companies are not allowed to promote so-called “off-label” uses, although doctors may prescribe them as they see fit. Earlier this year, New York State Attorney General Eliot Spitzer had asked Johnson & Johnson for marketing documents associated with several drugs, including Procrit.
Reuters reported on the story on October 1, 2004.